Peggy Scherle
Chief Tech/Sci/R&D Officer at PRELUDE THERAPEUTICS INCORPORATED
Net worth: - $ as of 2024-03-30
Profile
Peggy Scherle is Chief Scientific Officer of Prelude Therapeutics, Inc. In her past career she held the position of Vice President-Preclinical Pharmacology at Incyte Corp. She received a doctorate from the University of Pennsylvania and an undergraduate degree from Michigan State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-29 | 0 ( -.--% ) | - $ | 2024-03-30 |
Peggy Scherle active positions
| Companies | Position | Start |
|---|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | Chief Tech/Sci/R&D Officer | 2018-03-31 |
Former positions of Peggy Scherle
| Companies | Position | End |
|---|---|---|
| INCYTE CORPORATION | Corporate Officer/Principal | 2018-02-28 |
Training of Peggy Scherle
| Michigan State University | Undergraduate Degree |
| University of Pennsylvania | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
- Stock Market
- Insiders
- Peggy Scherle
